MD497G2 - Metodă de obţinere a materialului biologic pentru stabilirea activităţii aminotransferazelor sângelui - Google Patents

Metodă de obţinere a materialului biologic pentru stabilirea activităţii aminotransferazelor sângelui

Info

Publication number
MD497G2
MD497G2 MD96-0100A MD960100A MD497G2 MD 497 G2 MD497 G2 MD 497G2 MD 960100 A MD960100 A MD 960100A MD 497 G2 MD497 G2 MD 497G2
Authority
MD
Moldova
Prior art keywords
blood
activity
biological material
aminotransferases
determination
Prior art date
Application number
MD96-0100A
Other languages
English (en)
Russian (ru)
Other versions
MD497F1 (ro
Inventor
Tamara Sincariova
Lucia Vangheli
Original Assignee
Tamara Sincariova
Lucia Vangheli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tamara Sincariova, Lucia Vangheli filed Critical Tamara Sincariova
Priority to MD96-0100A priority Critical patent/MD497G2/ro
Publication of MD497F1 publication Critical patent/MD497F1/ro
Publication of MD497G2 publication Critical patent/MD497G2/ro

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Invenţia se referă la medicină, şi anume la diagnosticul de laborator, la metodele de obţinere a materialului biologic pentru stabilirea activităţii aminotransferazelor sângelui.Esenţa metodei propuse constă în aceea că în 0,3 ml soluţie se introduc 0,1 ml sânge capilar, amestecul se centrifughează timp de 10 min la 1000 rot./min, apoi se iau câte 0,1 ml lichid supernatant, acesta fiind material biologic pentru stabilirea activităţii aminotransferazelor, utilizat pentru proba experimentală şi proba-martor, conform metodei Reitman şi Frenkel.Rezultatul tehnic al metodei propuse constă în reducerea cantităţii de sânge prelevat.
MD96-0100A 1996-04-17 1996-04-17 Metodă de obţinere a materialului biologic pentru stabilirea activităţii aminotransferazelor sângelui MD497G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD96-0100A MD497G2 (ro) 1996-04-17 1996-04-17 Metodă de obţinere a materialului biologic pentru stabilirea activităţii aminotransferazelor sângelui

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD96-0100A MD497G2 (ro) 1996-04-17 1996-04-17 Metodă de obţinere a materialului biologic pentru stabilirea activităţii aminotransferazelor sângelui

Publications (2)

Publication Number Publication Date
MD497F1 MD497F1 (ro) 1996-10-31
MD497G2 true MD497G2 (ro) 1997-05-31

Family

ID=19738835

Family Applications (1)

Application Number Title Priority Date Filing Date
MD96-0100A MD497G2 (ro) 1996-04-17 1996-04-17 Metodă de obţinere a materialului biologic pentru stabilirea activităţii aminotransferazelor sângelui

Country Status (1)

Country Link
MD (1) MD497G2 (ro)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
А.Я.Любина, Ю.М.Неменова, М.Э.Полеес, Г.М.Чернобельская. "Руководство к практическим занятиям по технике лабораторных работ", 1988 г., "Медицина", M., c. 173. *
Йордан Тодоров. "Клинические лабораторные исследования в педиатрии", 1963 г., "Медицина и физкультура", c. 14. *

Also Published As

Publication number Publication date
MD497F1 (ro) 1996-10-31

Similar Documents

Publication Publication Date Title
Müller-Eberhard et al. C3 proactivator convertase and its mode of action
AU6933900A (en) Method, reagent and test cartridge for determining clotting time
DE58905236D1 (de) Verfahren zur modifizierung von molke.
ATE149846T1 (de) Apparat zur einbringung von medikamenten in rote blutkörperchen
SE9300105D0 (sv) Stable protein solution
Allen et al. Continuous monitoring of lipolytic rates in perifused isolated fat cells.
FR2701263B1 (fr) Procédé d'obtention d'une composition aqueuse protéinique, composition correspondante, glycoprotéine contenue et son utilisation pour la stabilisation de l'albumine et la détection ou le dosage d'anticorps.
BE900012A (fr) Nouveau peptide.
AU7379687A (en) A process for obtaining active proteins from a biologically inactive form
MD497G2 (ro) Metodă de obţinere a materialului biologic pentru stabilirea activităţii aminotransferazelor sângelui
Kingdon et al. Hemophilic dog model for evaluating therapeutic effectiveness of plasma protein fractions
JPS6479657A (en) Vital decision of medicine
ATE72756T1 (de) Verfahren zur herstellung eines biologischen stoffes.
AU715790B2 (en) Use of lofexidine in the manufacture of a medicament for treating attention deficit hyperactive disorder
US4082733A (en) Blocking protein fraction recovery method and product
Bond et al. Total blood, erythrocyte and plasma volumes in muscular dystrophic mice.
SU1666116A1 (ru) Способ лечени невралгии тройничного нерва
RU94038422A (ru) Способ оценки эффективности лечения атопического дерматита у детей
Drouhault et al. In-vivo hypocalcaemic, hypophosphataemic and hyperlipaemic activities in the common peptide sequence of adrenocorticotrophin, melanocyte-stimulating hormone and lipotrophin
UA6102A1 (uk) Спосіб визначення індивідуальної чутливості хворих до кемантану при хронічному обструктивному бронхіті
Stubbins et al. Inhibition of platelet aggregation by an irreversible local anesthetic
SUEMATSU et al. Effect of plasmapheresis on thyroid hormone section
FloraIPPOLITI PRELIMINARY RESEARCH ON ACUPUNCTURE EFFECTS IN IMMUNOLOGY
SU1524226A1 (ru) Способ получения аллергена из пчелиного яда
Garbin et al. Inhibitory effect of imipramine on epinephrine-dependent platelet aggregation:“In vitro” studies on platelets from healthy and depressed people

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20160417